Even the National Institutes of Health website will tell you there is no toxicity to B12
Critical Safety Gaps for Mental Health Applications Unknown effects on cognitive function, memory, personality, mood stability beyond intended therapeutic effect Long-term impacts on brain chemistry (chronic administration effects unexplored beyond 6 weeks in animals) Potential for psychological dependence or tolerance (not studied systematically) Impacts on developing brains in adolescents and young adults (completely unknown with no pediatric studies) Drug Interactions Pose Serious Concerns BPC-157s simultaneous effects on serotonin, dopamine, GABA, glutamate, and nitric oxide systems create multiple theoretical interaction points with psychiatric medications, yet interactions are not well studied. Specific concerns include: With SSRIs and SNRIs: Risk of serotonin syndrome is genuine
This parallel processing accelerates overall timelines and improves final outcomes
Crucially, unlike full-length hGH, AOD-9604 does not significantly elevate IGF-1 levels or negatively impact glucose tolerance, contributing to its favorable safety profile in clinical studies
Detailed Product Information: 30 x 250 mcg BPC-157 and 250 mcg TB-500 Gelatine Capsules ( Bovine-Derived ) Inactive Ingredient Filler: Grass-Fed Collagen
